Chitin Oligosaccharide (COS) Reduces Antibiotics Dose and Prevents Antibiotics-Caused Side Effects in Adolescent Idiopathic Scoliosis (AIS) Patients with Spinal Fusion Surgery.
Antibiotics are always considered for surgical site infection (SSI) in adolescent idiopathic scoliosis (AIS) surgery. However, the use of antibiotics often causes the antibiotic resistance of pathogens and side effects. Thus, it is necessary to explore natural products as drug candidates. Chitin Oligosaccharide (COS) has anti-inflammation and anti-bacteria functions. The effects of COS on surgical infection in AIS surgery were investigated. A total of 312 AIS patients were evenly and randomly assigned into control group (CG, each patient took one-gram alternative Azithromycin/Erythromycin/Cloxacillin/Aztreonam/Ceftazidime or combined daily), experiment group (EG, each patient took 20 mg COS and half-dose antibiotics daily), and placebo group (PG, each patient took 20 mg placebo and half-dose antibiotics daily). The average follow-up was one month, and infection severity and side effects were analyzed. The effects of COS on isolated pathogens were analyzed. SSI rates were 2%, 3% and 8% for spine wounds and 1%, 2% and 7% for iliac wound in CG, EG and PG (p< 0.05), respectively. COS reduces the side effects caused by antibiotics (p< 0.05). COS improved biochemical indexes and reduced the levels of interleukin (IL)-6 and tumor necrosis factor (TNF) alpha. COS reduced the antibiotics dose and antibiotics-caused side effects in AIS patients with spinal fusion surgery by improving antioxidant and anti-inflammatory activities. COS should be developed as potential adjuvant for antibiotics therapies.
Department of Orthopedics, The Second Hospital of JiLin University, Changchun 130041, China. quyang_22d@163.com.
Yang
Y
Qu
Department of Orthopedics, The Second Hospital of JiLin University, Changchun 130041, China. xujy0913@sina.com.
Jinyu
J
Xu
Department of Orthopedics, The Second Hospital of JiLin University, Changchun 130041, China. zhouhh1609@sina.com.
Haohan
H
Zhou
Department of Orthopedics, The Second Hospital of JiLin University, Changchun 130041, China. drpeng1507@sina.com.
Rongpeng
R
Dong
Department of Orthopedics, The Second Hospital of JiLin University, Changchun 130041, China. kmy_fge@126.com.
Mingyang
M
Kang
Department of Orthopedics, The Second Hospital of JiLin University, Changchun 130041, China. jianwu@jlu.edu.cn.
Jianwu
J
Zhao
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000627:therapeutic use*; D002648:Child; D002686:Chitin / Q000737:chemistry*; D005260:Female; D006801:Humans; D008297:Male; D009844:Oligosaccharides / Q000737:chemistry*; D012600:Scoliosis / Q000601:surgery*; D013123:Spinal Fusion / Q000379:methods; D013530:Surgical Wound Infection / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
D000900:Anti-Bacterial Agents; D009844:Oligosaccharides; D002686:Chitin
adolescent idiopathic scoliosis; antimicrobial prophylaxis; chitin oligosaccharide; spinal fusion